Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
China
· Delayed Price · Currency is CNY 6.09
+0.05 (0.83%)
Apr 30, 2025, 3:00 PM CST
SHA:600351 Revenue
In the year 2024, Yabao Pharmaceutical Group had annual revenue of 2.69B CNY, down -7.69%. Yabao Pharmaceutical Group had revenue of 614.53M in the quarter ending March 31, 2025, a decrease of -20.32%.
Revenue
2.69B
Revenue Growth
-7.69%
P/S Ratio
1.59
Revenue / Employee
648.49K
Employees
4,142
Market Cap
4.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.69B | -223.73M | -7.69% |
| Dec 31, 2023 | 2.91B | 191.63M | 7.05% |
| Dec 31, 2022 | 2.72B | -45.83M | -1.66% |
| Dec 31, 2021 | 2.76B | 161.54M | 6.21% |
| Dec 31, 2020 | 2.60B | -439.49M | -14.45% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |